Chronic Inflammatory and Immune Microenvironment Promote Hepatocellular Carcinoma Evolution

Area of Science:

• Hepatobiliary cancers
• Cancer immunology
• Tumor microenvironment

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally.
• Risk factors include viral hepatitis, alcohol abuse, and diabetes, all contributing to liver fibrosis.
• Chronic inflammation and a liver's immunosuppressive microenvironment are critical drivers of HCC development and progression.

Purpose of the Study:

• To review recent studies on the role of chronic inflammation in HCC.
• To discuss advanced mechanisms of immunosuppressive microenvironments in liver cancer.
• To identify potential therapeutic targets for HCC based on microenvironment modulation.

Main Methods:

• Literature review of recent scientific studies.
• Analysis of mechanisms involving inflammatory cytokines and free radicals.
• Examination of cellular and molecular players within the tumor microenvironment.

Main Results:

• Chronic inflammation promotes HCC through cytokines, free radicals, cell transformation, proliferation, and angiogenesis.
• The immunosuppressive liver microenvironment involves cancer-associated fibroblasts, regulatory T cells, myeloid-derived suppressor cells, and M2 macrophages.
• These microenvironmental factors collectively facilitate tumor growth and immune evasion.

Conclusions:

• The interplay between chronic inflammation and immunosuppression is central to HCC pathogenesis.
• Targeting these microenvironmental components offers promising therapeutic strategies for hepatocellular carcinoma.
• Further research into these mechanisms can lead to novel treatments for liver cancer.